Swirsky Douglas J
The estimated Net Worth of Swirsky Douglas J is at least $207,239.83 dollars as of 11/28/2021. Swirsky Douglas J is the President and CEO of Rexahn Pharmaceuticals Inc. Swirsky Douglas J owns over 1,042 shares of Rexahn Pharmaceuticals Inc stock worth over $7,544.08. Swirsky Douglas J is the Director of Cellectar Biosciences Inc. Swirsky Douglas J owns over 25,000 shares of Cellectar Biosciences Inc stock worth over $18,072.50. Swirsky Douglas J is the President & CEO of Genvec Inc. Swirsky Douglas J owns over 25,250 shares of Genvec Inc stock worth over $181,623.25.
|NeuroBo Pharmaceuticals Inc||2020-09-01||director|
|Cellectar Biosciences Inc||2020-06-24||director|
|Fibrocell Science Inc||2019-12-13||director|
|Rexahn Pharmaceuticals Inc||2019-01-29||director, officer: President and CEO|
|Pernix Therapeutics Holdings Inc||2018-05-22||director|
|Genvec Inc||2017-06-16||director, officer: President and CEO|
Swirsky Douglas J trading performance
Swirsky Douglas J trading performance analysis
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||-10.88||-20.25||-16.82||-34.53||-68.31||-54.09|
Swirsky Douglas J trading transactions
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.
Swirsky Douglas J personal network